The interferon receptor-1 promoter polymorphisms affect the outcome of Caucasians with HBeAg-negative chronic HBV infection

The interferon receptor-1 promoter polymorphisms affect the outcome of Caucasians with HBeAg-negative chronic HBV infection

The outcome of HBeAg-negative chronic hepatitis B virus (HBV) patients who may remain in the inactive carrier state (IC) or progress to HBeAg-negative chronic hepatitis B may be affected by the host genetic profile. Genetic polymorphisms within not only the promoter but also the coding sequence of t...

Bibliografski detalji
Glavni autori:	Karamitros, T, Papatheodoridis, G, Dimopoulou, E, Papageorgiou, M, Paraskevis, D, Magiorkinis, G, Sypsa, V, Hatzakis, A
Format:	Journal article
Jezik:	English
Izdano:	Wiley 2015

Slični predmeti

Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
Izdano: (2006-01-01)

Correlation between HBsAg quantitation and HBV DNA in HBeAg-Negative HBV/D patients
od: Anouar Teriaky, i dr.
Izdano: (2013-01-01)

HBeAg-negative chronic hepatitis
od: M M Ibragimova, i dr.
Izdano: (2004-02-01)

HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
od: Guangjun Song, i dr.
Izdano: (2023-11-01)

Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
od: Xiaomei Wang, i dr.
Izdano: (2020-10-01)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
od: Cheng-Yuan Peng, i dr.
Izdano: (2015-04-01)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
od: Zhan Zeng, i dr.
Izdano: (2023-01-01)

Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B.
od: Thilde Nordmann Winther, i dr.
Izdano: (2013-01-01)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
od: Michel Bazinet, i dr.
Izdano: (2022-08-01)

Study of hepatic histomorphology in HBeAg+ and HBeAg− patients with CHB: Experience from Bangladesh
od: Ayub Al Mamun, i dr.
Izdano: (2013-01-01)

Immunomodulatory Function of HBeAg Related to Short-Sighted Evolution, Transmissibility, and Clinical Manifestation of Hepatitis B Virus
od: Anna Kramvis, i dr.
Izdano: (2018-10-01)

Envelope antibody HBeIgG and HBV DNA in HBeAg-seronegative young adults in Nigeria
od: Mathew Folaranmi Olaniyan, i dr.
Izdano: (2023-09-01)

Is the function of the HBeAg really unknown?
od: David R. Milich
Izdano: (2019-09-01)

Mathematical investigation of HBeAg seroclearance
od: Sarah Kadelka, i dr.
Izdano: (2019-08-01)

HBeAg negative chronic hepatitis B in South Asia
od: Ananta Shrestha, i dr.
Izdano: (2016-11-01)

Impact of interferon-alpha receptor-1 promoter polymorphisms on the transcriptome of the hepatitis B virus-associated hepatocellular carcinoma
od: Karamitros, T, i dr.
Izdano: (2018)

Predictive significance of serum pgRNA in HBeAg clearance for chronic hepatitis B patients with low HBeAg level after pegylated interferon treatment
od: LIU Zhongwei, i dr.
Izdano: (2022-01-01)

Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α
od: Kaimin Song, i dr.
Izdano: (2025-02-01)

Comparison of evolutionary patterns of different HBeAg status in HBV genotype B and C
od: Cai Ying, i dr.
Izdano: (2015-12-01)

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
od: Crozier Sarah, i dr.
Izdano: (2008-04-01)

The intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China.
od: Hui Wang, i dr.
Izdano: (2014-01-01)

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
od: Byung-Cheol Song, i dr.
Izdano: (2014-12-01)

Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
od: Timokratis Karamitros, i dr.
Izdano: (2018-04-01)

Mitogen-activated protein kinase eight polymorphisms are associated with immune responsiveness to HBV vaccinations in infants of HBsAg(+)/HBeAg(−) mothers
od: Meng Zhuo Cao, i dr.
Izdano: (2018-06-01)

Lamivudine therapy in HBeAg negative chronic hepatitis B patients
od: E. Guclu, i dr.
Izdano: (2014-04-01)

Increased Coffee Intake Reduces Circulating HBV DNA and HBsAg Levels in HBeAg-Negative Infection: A Cohort Study
od: Jack Bee Chook, i dr.
Izdano: (2019-09-01)

Manifestations of perihepatic lymph nodes in acute flare of chronic hepatitis B: association with HBeAg status and with HBeAg seroconversion.
od: Yen-Ling Ko, i dr.
Izdano: (2015-01-01)

Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection.
od: Victoria Therese Mücke, i dr.
Izdano: (2018-01-01)

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
od: Chih-Chien Yao, i dr.
Izdano: (2017-05-01)

Phenotypes of peripheral CD4+ T helper cell subsets in pregnant women with HBeAg-negative chronic asymptomatic HBV carriers
od: Guofang Feng, i dr.
Izdano: (2023-02-01)

Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection
od: Anna D. Kosinska, i dr.
Izdano: (2021-07-01)

Caucasian Ethnicity, but Not Treatment Cessation Is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion
od: Stijn Van Hees, i dr.
Izdano: (2019-07-01)

Characterization of HBeAg-negative chronic hepatitis B in western Brazilian Amazonia
od: Flamir da Silva Victoria, i dr.

HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History
od: Ferruccio Bonino, i dr.
Izdano: (2022-07-01)

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.
od: Tung-Hung Su, i dr.
Izdano: (2013-01-01)

A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues
od: Yan Gu, i dr.
Izdano: (2024-01-01)

IL28B polymorphism correlates with active hepatitis in patients with HBeAg-negative chronic hepatitis B.
od: I-Cheng Lee, i dr.
Izdano: (2013-01-01)

Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase
od: Yuhua Gao, i dr.
Izdano: (2024-04-01)

Comparison of antibody response to hepatitis B vaccination in infants with positive or negative maternal hepatitis B e antigen (HBeAg) in cord blood: implication for the role of HBeAg as an immunotolerogen
od: Hongyu Huang, i dr.
Izdano: (2019-09-01)

CTLA-4 haplotype predicts HBsAg and HBcrAg levels and HBeAg seroconversion age in children with chronic HBV infection
od: Jia-Feng Wu, i dr.
Izdano: (2024-05-01)